ICER's Sarah Emond and @dano-hta.bsky.social will be speaking at the CDA Symposium this month! Register here to attend virtually: web.cvent.com/event/07b935...

#CDAAMC26

Thank you @cda-amc.bsky.social for highlighting MDSC's work on mental health meds & HTA blind spots. Grateful to panel for expertise & lived experience. Shared Value Consideration Framework to reflect real-world outcomes & equity gaps.
Visit: accesstomedication.mdsc.ca
#HealthEquity #CDAAMC26

(4/4) Thank you to Patrick Bedford, Josée Champagne, Jason Guertin, Dr. Denis-Claude Roy, and Dr. Bernard Thébaud for joining the discussion and sharing their perspectives across clinical care, research, policy, and biomanufacturing. #CDAAMC26

(3/3) and prioritizes Canadian-developed therapies for patients is essential. 

Thanks to my fellow speakers Stéphanie Michaud, Chris Kamel, and Camille Leahy and to everyone who joined us for this important conversation.

Read the Watch List report here: www.cda- amc.ca/watchlist2026 #CDAAMC26

It's been a few years but really excited to be back at Canada's Drug Agency Symposium 2026!

Off to a great start with a plenary on international approaches to HTA with Suzanne McGurn, Sarah Emond, Natalie M., and Yannis Natsis.

#CDAAMC26